Identity
- Trade Name
- Anti-S100P FDA UDI
- Generic Name
- S100 protein IVD, antibody FDA UDI
- Model / Reference
- AM993-10M FDA UDI
Identifiers
- Catalog Number
- AM993-10M FDA UDI
- Primary DI / UDI-DI
- 00810119678010 FDA UDI
- FDA Product Code
- NJT FDA UDI
- GMDN Term
- S100 protein IVD, antibody FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 864.1860 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Dimensions & Sizes
- Size
- Total Volume — 10 Milliliter FDA UDI
Category: S100 protein IVD, antibody
Anti-S100P by Biogenex Laboratories, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as S100 protein IVD, antibody.
- S100P (16/f5) Mouse Monoclonal Antibody — CELL MARQUE CORPORATION · Class I
- Tinto S100A8/MRP8 (RBT-MRP8) — BIO SB, INC. · Class I
- S100P (RBT-S100P) — BIO SB, INC. · Class I
- S100 beta (EP32) Rabbit Monoclonal Primary Antibody — CELL MARQUE CORPORATION · Class I
- Tissue-Tek Genie® — Sakura Finetek USA, Inc · Class I
- IHC — Slmp, LLC · Class I
- Tinto S100A6 RMab — BIO SB, INC. · Class I
- S100A9 RMab — BIO SB, INC. · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Biogenex Laboratories, Inc.
Sources (1)
- FDA UDI 52fddba2-836d-4994-a036-00a697ec8605 36 fields · synced May 30, 2026